论文部分内容阅读
目的：用批判的眼光综述人附睾蛋白4(HE4)在卵巢癌诊断中的研究进展。方法：在全面检索的基础上，从检测临床肿瘤标记物应用的基本原则、种族和人群差异、影响HE4测定的因素、检测方法和试剂来综述相关研究文献。
人附睾蛋白4诊断卵巢癌的相关研究进展
【摘 要】
：
目的：用批判的眼光综述人附睾蛋白4(HE4)在卵巢癌诊断中的研究进展。方法：在全面检索的基础上，从检测临床肿瘤标记物应用的基本原则、种族和人群差异、影响HE4测定的因素、
【机 构】
：
赣州 赣南医学院第一附属医院妇产科
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年期
其他文献
Quadruple Squamous Cell Carcinoma after allogeneic hematopoietic stem-cell transplantation for Leuke
Objective: We experienced a rare case of quadruple squamous cell carcinoma of the gut mucosa and skin after allogeneic hematopoietic stem-cell transplantati
会议
Objective: The outcome of extramedullary plasmacytomas(EMPs) in patients with multiple myeloma (MM)is poor.Method: We retrospectively studied the clinical c
会议
PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell l
Objective: Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is an aggressive malignancy that is largely resistant to current therapeuti
会议
Objective: While the epidemiologic association between hepatitis B virus (HBV) infection and diffuse large B-cell lymphoma (DLBCL) is established, little is
会议
Objective: Primary laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma is extremely rare.To date, clinical research has been focused on extranodal M
会议
Prognostic value of interim 18F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-base
Objective: The prognostic value of an interim fluorine-18-fluorodeoxyglucose positron emission tomogramphy (18F-FDG PET) for diffuse large B-cell lymphoma (
会议
ENDOSCOPIC MENIFESTATIONS OF DIGESTIVE INFILTRATION AFFECTED BY LEUKEMIC CELLS FROM PATIENTS WITH DI
Objective: To summerize endoscopic characteristics of digestive infiltration affected by leukemic cells with digestive tract bleeding.Method: We retrospecte
会议
Objective: To explore the influencing factors on accuracy and consistency of clinical and pathological diagnosis of lymphoma, and its effect on treatment.
会议
Survival spectrum of patients with primary refractory DLBCL: standard salvage chemotherapy might not
Objective: Addition of theanti-CD20 monoclonal antibody Rituximab to chemotherapies has improved the outcome of DLBCL with over 50% of patients achieving lo
会议